FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2113996395> ?p ?o ?g. }

• W2113996395 endingPage "S695" @default.
• W2113996395 startingPage "S695" @default.
• W2113996395 abstract "Poly (ADP-ribose) polymerase-1 (PARP-1) is a key enzyme involved in the repair of radiation-induced single-strand DNA breaks. PARP inhibitors such as olaparib (KU-0059436, AZD-2281) enhance tumor sensitivity to radiation and to topoisomerase I inhibitors like camptothecin (CPT). Olaparib is an orally bioavailable inhibitor of PARP-1 and PARP-2 that has been tested in multiple clinical trials. The purpose of this study was to investigate the characteristics of the sensitizing effect of olaparib for radiation and CPT in order to support clinical application of this agent. DLD-1 cells (a human colorectal cancer cell line) and H1299 cells (a non-small cell lung cancer cell line) with differences of p53 gene status were used. Survival curves of these cells were determined by clonogenic assay after treatment with drugs and X-ray irradiation. The γH2AX focus formation assay was performed to examine the influence of olaparib on induction and repair of double-stranded DNA breaks after exposure to radiation or CPT. A radiosensitizing effect of olaparib was seen even at 0.01 μM. Its radiosensitizing effect after exposure for 2 h was similar to that after 24 h. H1299 cells with depletion or mutation of p53 were more radioresistant than H1299 cells with wild-type p53. However, similar enhancement of radiosensitization by olaparib was observed with all of the tested cell lines regardless of the p53 status. Olaparib also sensitized cells to CPT. This sensitizing effect was seen at low concentrations of olaparib such as 0.01 μM, and its sensitizing effect was the same at both 0.01 μM and 1 μM. The combination of olaparib and CPT had a stronger radiosensitizing effect. The results of the γH2AX focus assay corresponded with the clonogenic assay findings. Olaparib enhanced sensitivity to radiation and CPT at low concentrations and after relatively short exposure times such as 2 h. The radiosensitizing effect of olaparib was not dependent on the p53 status of tumor cells. These characteristics could be advantageous for clinical radiation therapy since tumor cells may be exposed to low concentrations of olaparib and/or may have P53 mutation. The combination of olaparib and CPT had a stronger radiosensitizing effect, indicating that combining a PARP inhibitor with a topoiomerase I inhibitor could be promising for clinical radiosensitization." @default.
• W2113996395 created "2016-06-24" @default.
• W2113996395 creator A5008695443 @default.
• W2113996395 creator A5019113765 @default.
• W2113996395 creator A5019366369 @default.
• W2113996395 creator A5024523151 @default.
• W2113996395 creator A5037201209 @default.
• W2113996395 creator A5039115614 @default.
• W2113996395 creator A5041956835 @default.
• W2113996395 date "2012-11-01" @default.
• W2113996395 modified "2023-09-25" @default.
• W2113996395 title "The Combination of Olaparib and Camptothecin Effectively Sensitize Radiation" @default.
• W2113996395 doi "https://doi.org/10.1016/j.ijrobp.2012.07.1857" @default.
• W2113996395 hasPublicationYear "2012" @default.
• W2113996395 type Work @default.
• W2113996395 sameAs 2113996395 @default.
• W2113996395 citedByCount "0" @default.
• W2113996395 crossrefType "journal-article" @default.
• W2113996395 hasAuthorship W2113996395A5008695443 @default.
• W2113996395 hasAuthorship W2113996395A5019113765 @default.
• W2113996395 hasAuthorship W2113996395A5019366369 @default.
• W2113996395 hasAuthorship W2113996395A5024523151 @default.
• W2113996395 hasAuthorship W2113996395A5037201209 @default.
• W2113996395 hasAuthorship W2113996395A5039115614 @default.
• W2113996395 hasAuthorship W2113996395A5041956835 @default.
• W2113996395 hasBestOaLocation W21139963951 @default.
• W2113996395 hasConcept C117262875 @default.
• W2113996395 hasConcept C126322002 @default.
• W2113996395 hasConcept C134935766 @default.
• W2113996395 hasConcept C143425029 @default.
• W2113996395 hasConcept C147897179 @default.
• W2113996395 hasConcept C181199279 @default.
• W2113996395 hasConcept C182979987 @default.
• W2113996395 hasConcept C202751555 @default.
• W2113996395 hasConcept C2776428644 @default.
• W2113996395 hasConcept C2778502085 @default.
• W2113996395 hasConcept C2779138821 @default.
• W2113996395 hasConcept C2779682216 @default.
• W2113996395 hasConcept C2779962180 @default.
• W2113996395 hasConcept C502942594 @default.
• W2113996395 hasConcept C509974204 @default.
• W2113996395 hasConcept C54355233 @default.
• W2113996395 hasConcept C552990157 @default.
• W2113996395 hasConcept C55493867 @default.
• W2113996395 hasConcept C58962609 @default.
• W2113996395 hasConcept C71924100 @default.
• W2113996395 hasConcept C81885089 @default.
• W2113996395 hasConcept C82381507 @default.
• W2113996395 hasConcept C86803240 @default.
• W2113996395 hasConceptScore W2113996395C117262875 @default.
• W2113996395 hasConceptScore W2113996395C126322002 @default.
• W2113996395 hasConceptScore W2113996395C134935766 @default.
• W2113996395 hasConceptScore W2113996395C143425029 @default.
• W2113996395 hasConceptScore W2113996395C147897179 @default.
• W2113996395 hasConceptScore W2113996395C181199279 @default.
• W2113996395 hasConceptScore W2113996395C182979987 @default.
• W2113996395 hasConceptScore W2113996395C202751555 @default.
• W2113996395 hasConceptScore W2113996395C2776428644 @default.
• W2113996395 hasConceptScore W2113996395C2778502085 @default.
• W2113996395 hasConceptScore W2113996395C2779138821 @default.
• W2113996395 hasConceptScore W2113996395C2779682216 @default.
• W2113996395 hasConceptScore W2113996395C2779962180 @default.
• W2113996395 hasConceptScore W2113996395C502942594 @default.
• W2113996395 hasConceptScore W2113996395C509974204 @default.
• W2113996395 hasConceptScore W2113996395C54355233 @default.
• W2113996395 hasConceptScore W2113996395C552990157 @default.
• W2113996395 hasConceptScore W2113996395C55493867 @default.
• W2113996395 hasConceptScore W2113996395C58962609 @default.
• W2113996395 hasConceptScore W2113996395C71924100 @default.
• W2113996395 hasConceptScore W2113996395C81885089 @default.
• W2113996395 hasConceptScore W2113996395C82381507 @default.
• W2113996395 hasConceptScore W2113996395C86803240 @default.
• W2113996395 hasIssue "3" @default.
• W2113996395 hasLocation W21139963951 @default.
• W2113996395 hasOpenAccess W2113996395 @default.
• W2113996395 hasPrimaryLocation W21139963951 @default.
• W2113996395 hasRelatedWork W1993344194 @default.
• W2113996395 hasRelatedWork W2001870355 @default.
• W2113996395 hasRelatedWork W2027413502 @default.
• W2113996395 hasRelatedWork W2131874020 @default.
• W2113996395 hasRelatedWork W2161316257 @default.
• W2113996395 hasRelatedWork W2742035863 @default.
• W2113996395 hasRelatedWork W2953858362 @default.
• W2113996395 hasRelatedWork W3208048504 @default.
• W2113996395 hasRelatedWork W4281712344 @default.
• W2113996395 hasRelatedWork W4290085956 @default.
• W2113996395 hasVolume "84" @default.
• W2113996395 isParatext "false" @default.
• W2113996395 isRetracted "false" @default.
• W2113996395 magId "2113996395" @default.
• W2113996395 workType "article" @default.